Delivery Order SPE2DB20D1004-SPE2DB21FG1J8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,092.72 delivery order is for the pharmaceutical product LANTUS SOLOSTAR 100 UNIT/ML 3ML, with a completion date of January 19, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,164.26 delivery order is for the pharmaceutical product LANTUS SOLOSTAR 100 UNIT/ML 3ML. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,810.86 for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 12, 2021, with an ultimate completion date of October 13, 2021. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,187.20, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication, to support military healthcare programs. The award is not associated with any set-aside designation, indicating it was competed on an open basis. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to the U.S. government. The contract has a ceiling value of $1,187.60 and is a firm-fixed price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The Delivery Order has a ceiling value of $1,440.30 and was awarded on February 7, 2022, with a completion date of February 8, 2022. The contract is a Firm Fixed Price...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The award, valued at $5,376.00, is for the delivery of Lantus Solostar 100 Unit/mL 3mL, a specialty medication used to treat diabetes. The contract does not have a set-aside designation, indicating open competition. As...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $2,620.70 Firm Fixed Price Delivery Order for the supply of 4563337065 LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract, awarded by the Defense Logistics Agency (DLA), has a performance period ending on January 17, 2024. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a specialty pharmaceutical product used for diabetes management. The award has a ceiling value of $2,374.40 and an ultimate completion date of August 29, 2022. The contract is a firm...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $1,408.70 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The award has an ultimate completion date of March 8, 2024 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FG1J8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) with a ceiling value of $2,374.40. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medical product used in the treatment of diabetes. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific Delivery Order is part of that larger IDC contract. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/28/21 |